Novo Nordisk Investigational Site is a clinical research site located in Ozark, Alabama, United States 36360.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Novo Nordisk Investigational Site has participated in 4 clinical trials.
Therapeutic areas: Diabetes, Diabetes Mellitus, Type 2.
Sponsors: Novo Nordisk A/S.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novo Nordisk Investigational Site has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novo Nordisk Investigational Site has 4 clinical trials on record. Their work covers Diabetes, Diabetes Mellitus, Type 2.
Novo Nordisk Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.